Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Cash from Investing Activities (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Cash from Investing Activities for 5 consecutive years, with -$1000.0 as the latest value for Q3 2020.

  • Quarterly Cash from Investing Activities rose 99.98% to -$1000.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2020, up 2311.11% year-over-year, with the annual reading at $36.2 million for FY2025, 200.67% up from the prior year.
  • Cash from Investing Activities for Q3 2020 was -$1000.0 at Forte Biosciences, up from -$9.1 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $12.7 million in Q1 2020, with the low at -$28.4 million in Q4 2017.
  • Average Cash from Investing Activities over 5 years is -$205789.5, with a median of $756000.0 recorded in 2018.
  • The sharpest move saw Cash from Investing Activities surged 266.54% in 2019, then plummeted 2150.99% in 2020.
  • Over 5 years, Cash from Investing Activities stood at $6.8 million in 2016, then crashed by 515.28% to -$28.4 million in 2017, then surged by 102.66% to $756000.0 in 2018, then crashed by 111.77% to -$89000.0 in 2019, then surged by 98.88% to -$1000.0 in 2020.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$1000.0, -$9.1 million, and $12.7 million for Q3 2020, Q2 2020, and Q1 2020 respectively.